Minireviews
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Nov 16, 2014; 2(11): 654-660
Published online Nov 16, 2014. doi: 10.12998/wjcc.v2.i11.654
Table 1 Risk factors associated with scrotal squamous cell carcinoma
Occupations
Chimney sweepers, tar and paraffin workers, occupations with exposure to mineral and cutting oils, printing, metal working, car and aeroplane manufacture, car mechanics, commercial printing, aluminum worker, shale oil workers, pitch workers, engineering, steel production, cavalrymen
Carcinogenic metals
Arsenic, nickel, chromium
Chronic mechanical irritation
Chronic inflammatory states
Chronic lymphedema, infective and surgical scars
Lifestyle
Poor personal hygiene, smoking
Viruses
HPV
Ionizing Radiation
Iatrogenic
Coal tar, PUVA, radiotherapy, nitrogen mustard, Fowler’s solution
Immunosuppression
Acquired and inherited immunodeficiency, post transplant immunosuppression
Table 2 Lowe’s staging of scrotal squamous cell carcinoma
A1Disease localized to scrotum
A2Locally extensive disease involving adjacent structures (penis, perineum, testis or cord, and pubic bone) by continuity but without evident metastasis
BSuperficial lymph node metastasis, resectable
CPelvic lymph node metastasis or any unresectable metastasis
DDistant metastasis beyond regional nodes
Table 3 TNM staging system for squamous cell carcinoma
StagePrimary tumourRegional lymph nodesDistant metastasis
Stage 0Tis = carcinoma in situN0 = no regional lymph node involvementM0
Stage IT1 = tumour 2 cm or lessN0M0
Stage IIT2 = tumour > 2 cm but < 5 cmN0M0
T3 = tumour > 5 cmN0M0
Stage IIIT4 = Invasion of deeper extradermal structuresN0M0
Any TN1 = regional lymph node spread.M0
Stage IVAny TAny NM1 = distant metastasis.
Table 4 Case series with epidemiology, management and outcomes of scrotal squamous cell carcinoma published after 2000
Ref.nDesignCohort characteristics Summary
Stern et al[17], 200217Prospective multi-institutional cohort study892 men first treated with PUVADose-dependent increase in the risk of genital tumors in men treated with PUVA
Seabra et al[19], 20076Retrospective single institutionAge: 52 (31-89) Race: Ca: 2; Bl: 2; Oth: 1; Unknown: 1 Staging: LC: 4, RL: 1, DD: 14/6 WLE; 1/6 WLE + SLNB; 1/6 was unresectable: 1 developed LN metastasis and was treated with chemo/radiation Patient with unresectable disease and was treated with chemotherapy and subsequently died
Wright et al[2], 2008151SEER (1973-2002)Age: 682 Race: Ca 117 (77.5); Bl 24 (15.9); Oth 10 (6.6)SCC had the worse survival compared to other histological subtypes
Verhoeven et al[1], 201053NCR (1989-2006)Age: 56.5 Staging: Stg 0: 1 (1.9), Stg 1: 22 (41.5), Stg 2: 18 (34), Stg 3: 2 (3.8), Stg 4: 0, Unk: 10 (18.9)SCC had the worse survival compared to other histological subtypes: 1 yr relative survival 93% 3 yr relative survival 80% 5 yr relative survival 77%
Johnson et al[16], 2013269SEER (1973-2006)Age: 65.42± 14.9 Race: Ca 206 (76.6%), Bl 43 (16.0%), As 12 (4.5%), Hi 18 (6.7%), Oth 8 (3.0%) Staging: LC 205 (76.2%), RL 54 (20.1%), DD 10 (3.7%)The median OS for patients with SCC was 115 (95%CI: 97-133) mo
Matoso et al[18], 201429Retrospective multi-institutionalAge: 55 (30-74) Race: Ca 19 (65.5%), Bl 10 (34.5%) Follow up: 37 mo25/29 WLE; 1/29 WLE + LND; 3/29 imiquimod post WLE: 13 (45%) with1 margins required re-excision1 3/29 local recurrence: 2 WLE; 1 WLE/RT 3 /29 with lymphadenopathy lost to follow-up